Gökhan Çakırca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gökhan Çakırca has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Akif Bozdayi
Department of Medical Biochemistry, Mehmet Akif Inan Education and Research Hospital, Sanliurfa, Türkiye
6 shared publications Ayşe Torun
Department of Infectious Diseases and Clinical Microbiology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey
3 shared publications- İsMet Gamze Bozdayi
Department of Medical Biochemistry, Sanliurfa Education and Research Hospital, Sanliurfa, Türkiye
3 shared publications Tuba Damar Çakırca
Department of Infectious Diseases and Clinical Microbiology, Sanliurfa Training and Research Hospital, Sanliurfa, Turkey
3 shared publications- Tuba Damar Çakırca
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Harran University, Şanlıurfa 63300, Türkiye
3 shared publications Ahmet Guzelcicek
Department of Pediatrics, Harran University, Faculty of Medicine, Sanliurfa, Turkey
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Caleo
Evaluation of Analytical Process Performance of Urine Creatinine Using Different Quality Assessment Models in a Toxicology Laboratory
Objective: This study aimed to evaluate the analytical process performance of the urine creatinine test, which is routinely used within urine specimen validity testing, by applying measurement uncertainty (MU), total analytical error (TAE), and sigma metric performance assessment models. In addition, the authors investigated the impact of MU on decision limits used for dilution assessment.Methods: External quality assessment and internal quality control data for urine creatinine testing were obtained retrospectively. Expanded MU, TAE, and sigma metrics were subsequently calculated.Results: The expanded MU calculated according to the Nordtest approach was 17.70%. Based on this uncertainty, the adjusted upper decision limit for dilution was determined as 20 ± 3.5 mg/dL, and the lower decision limit as 4.5 ± 0.8 mg/dL. Overall, 1.5% of the reported urine creatinine results fell within the uncertainty-adjusted decision limit ranges. Total analytical error was calculated as 17.26% for the low level and 13.84% for the high level. Sigma metric values showed substantial variation depending on the selected allowable total error specification.Conclusion: Continuous monitoring of analytical performance indicators for urine creatinine can assist laboratory professionals in evaluating and improving result reliability. Moreover, awareness of these performance characteristics by individuals interpreting test results may further enhance confidence in reported values. The findings of this study highlight the importance of incorporating laboratory-specific MU into the interpretation of urine creatinine results near dilution decision limits. The authors also suggest that defining analytical performance targets for laboratory tests in relevant guidelines would be beneficial for the standardization of result quality.
- 6 November 2026
- Published by Caleo
Open AccessEvaluation of Analytical Process Performance of Urine Creatinine Using Different Quality Assessment Models in a Toxicology Laboratory
Objective: This study aimed to evaluate the analytical process performance of the urine creatinine test, which is routinely used within urine specimen validity testing, by applying measurement uncertainty (MU), total analytical error (TAE), and sigma metric performance assessment models. In addition, the authors investigated the impact of MU on decision limits used for dilution assessment.Methods: External quality assessment and internal quality control data for urine creatinine testing were obtained retrospectively. Expanded MU, TAE, and sigma metrics were subsequently calculated.Results: The expanded MU calculated according to the Nordtest approach was 17.70%. Based on this uncertainty, the adjusted upper decision limit for dilution was determined as 20 ± 3.5 mg/dL, and the lower decision limit as 4.5 ± 0.8 mg/dL. Overall, 1.5% of the reported urine creatinine results fell within the uncertainty-adjusted decision limit ranges. Total analytical error was calculated as 17.26% for the low level and 13.84% for the high level. Sigma metric values showed substantial variation depending on the selected allowable total error specification.Conclusion: Continuous monitoring of analytical performance indicators for urine creatinine can assist laboratory professionals in evaluating and improving result reliability. Moreover, awareness of these performance characteristics by individuals interpreting test results may further enhance confidence in reported values. The findings of this study highlight the importance of incorporating laboratory-specific MU into the interpretation of urine creatinine results near dilution decision limits. The authors also suggest that defining analytical performance targets for laboratory tests in relevant guidelines would be beneficial for the standardization of result quality.
- Open Access
- 26 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 1995
Vitamin D Status and Routine Laboratory Data-Derived 25(OH)D Distributional Benchmarks in Adults from Şanlıurfa, Türkiye: Age, Sex, and Seasonal Variation
Background: Serum 25-hydroxyvitamin D [25(OH)D] interpretation requires clear distinction between epidemiological thresholds, routine-data distributions, and clinical decision limits. This study evaluated vitamin D status and clinically pre-filtered routine laboratory data-derived 25(OH)D distributional benchmarks among adults from Şanlıurfa, southeastern Türkiye, according to sex, age, and season. Methods: This retrospective single-center routine laboratory database study included adults aged 18–65 years tested between 1 January and 31 December 2025, at the Medical Biochemistry Laboratory of Şanlıurfa Mehmet Akif İnan Training and Research Hospital. After eligibility screening, duplicate removal, analytical screening, and predefined clinical pre-filtering, 48,826 participant-level records were analyzed. Serum 25(OH)D was measured using the Elecsys Vitamin D total III electrochemiluminescence immunoassay on a cobas e 801 analyzer/module. The primary distributional estimate was the nonparametric 2.5th–97.5th percentile range. Results: Median age was 38 [28–49] years, and 35,043 records were from female participants (71.8%). Median serum 25(OH)D was 12.74 [8.28–19.00] ng/mL. Vitamin D deficiency, severe deficiency, insufficiency, and sufficiency were observed in 38,072 (78.0%), 17,163 (35.2%), 8235 (16.9%), and 2519 (5.2%) records, respectively. Lower 25(OH)D concentrations and higher deficiency prevalence were observed among females, younger adults, and winter/spring samples, with small-to-modest effect magnitudes. The clinically pre-filtered routine-data 2.5th–97.5th percentile range was 3.46–35.50 ng/mL. Conclusions : Low 25(OH)D status was widespread among routinely tested adults in Şanlıurfa. The derived range should be interpreted only as a local routine-data distributional benchmark for the tested population, not as a healthy-volunteer reference interval, clinical sufficiency threshold, treatment threshold, or clinical decision limit.
- 26 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (13) , 1995
Open AccessVitamin D Status and Routine Laboratory Data-Derived 25(OH)D Distributional Benchmarks in Adults from Şanlıurfa, Türkiye: Age, Sex, and Seasonal Variation
Background: Serum 25-hydroxyvitamin D [25(OH)D] interpretation requires clear distinction between epidemiological thresholds, routine-data distributions, and clinical decision limits. This study evaluated vitamin D status and clinically pre-filtered routine laboratory data-derived 25(OH)D distributional benchmarks among adults from Şanlıurfa, southeastern Türkiye, according to sex, age, and season. Methods: This retrospective single-center routine laboratory database study included adults aged 18–65 years tested between 1 January and 31 December 2025, at the Medical Biochemistry Laboratory of Şanlıurfa Mehmet Akif İnan Training and Research Hospital. After eligibility screening, duplicate removal, analytical screening, and predefined clinical pre-filtering, 48,826 participant-level records were analyzed. Serum 25(OH)D was measured using the Elecsys Vitamin D total III electrochemiluminescence immunoassay on a cobas e 801 analyzer/module. The primary distributional estimate was the nonparametric 2.5th–97.5th percentile range. Results: Median age was 38 [28–49] years, and 35,043 records were from female participants (71.8%). Median serum 25(OH)D was 12.74 [8.28–19.00] ng/mL. Vitamin D deficiency, severe deficiency, insufficiency, and sufficiency were observed in 38,072 (78.0%), 17,163 (35.2%), 8235 (16.9%), and 2519 (5.2%) records, respectively. Lower 25(OH)D concentrations and higher deficiency prevalence were observed among females, younger adults, and winter/spring samples, with small-to-modest effect magnitudes. The clinically pre-filtered routine-data 2.5th–97.5th percentile range was 3.46–35.50 ng/mL. Conclusions : Low 25(OH)D status was widespread among routinely tested adults in Şanlıurfa. The derived range should be interpreted only as a local routine-data distributional benchmark for the tested population, not as a healthy-volunteer reference interval, clinical sufficiency threshold, treatment threshold, or clinical decision limit.
- 30 December 2025
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 23 (3) , 098-105
Trends in Ethanol Positivity by Age and Gender: A Laboratory-Based Study
Amaç: Bu çalışmada, dört yıl boyunca analiz edilen etanol sonuçlarının yaş, cinsiyet ve etanol konsantrasyon düzeylerine göre dağılımlarını ve pozitiflik eğilimlerini değerlendirmeyi amaçladık. Gereç ve Yöntem: Bu retrospektif çalışmada, 1 Ocak 2021 ile 31 Aralık 2024 tarihleri arasında hastanemiz laboratuvarında gerçekleştirilen toplam 11.684 etanol analiz sonucu laboratuvar bilgi sisteminden elde edildi. Etanol sonuçları yaş gruplarına (≤19 yıl, 20-34 yıl, 35-50 yıl ve >50 yıl), cinsiyete ve etanol konsantrasyon düzeylerine (50 mg/dL) göre kategorize edildi. ≥ 10 mg/dL etanol düzeyleri pozitif olarak kabul edildi. Bulgular: 10.868 erkek vakanın 1.355'inde (%12,5) ve 816 kadın vakanın 94'ünde (%11,5) etanol pozitifliği saptandı. En fazla test sayısı ve en yüksek pozitiflik oranı (%13,7) tüm pozitif vakaların %56,3'ünü oluşturan 20-34 yaş grubunda görüldü. Dört yıllık süreçte saptanan 1.449 etanol pozitif vakanın %93,5'i erkek, %6,5'i kadındı. Etanol konsantrasyonu 50 mg/dL olan vakaların sayısı ise 1.084 (%9,3) olarak bulundu. Sonuç: Etanol pozitifliği en sık 20-34 yaş aralığındaki genç yetişkinlerde gözlendi. Dört yıllık süre boyunca, ≤19, 35-50 ve >50 yaş gruplarında etanol pozitifliği oranlarında istikrarlı bir düşüş görüldü.
- 30 December 2025
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 23 (3) , 098-105
Trends in Ethanol Positivity by Age and Gender: A Laboratory-Based Study
Amaç: Bu çalışmada, dört yıl boyunca analiz edilen etanol sonuçlarının yaş, cinsiyet ve etanol konsantrasyon düzeylerine göre dağılımlarını ve pozitiflik eğilimlerini değerlendirmeyi amaçladık. Gereç ve Yöntem: Bu retrospektif çalışmada, 1 Ocak 2021 ile 31 Aralık 2024 tarihleri arasında hastanemiz laboratuvarında gerçekleştirilen toplam 11.684 etanol analiz sonucu laboratuvar bilgi sisteminden elde edildi. Etanol sonuçları yaş gruplarına (≤19 yıl, 20-34 yıl, 35-50 yıl ve >50 yıl), cinsiyete ve etanol konsantrasyon düzeylerine (50 mg/dL) göre kategorize edildi. ≥ 10 mg/dL etanol düzeyleri pozitif olarak kabul edildi. Bulgular: 10.868 erkek vakanın 1.355'inde (%12,5) ve 816 kadın vakanın 94'ünde (%11,5) etanol pozitifliği saptandı. En fazla test sayısı ve en yüksek pozitiflik oranı (%13,7) tüm pozitif vakaların %56,3'ünü oluşturan 20-34 yaş grubunda görüldü. Dört yıllık süreçte saptanan 1.449 etanol pozitif vakanın %93,5'i erkek, %6,5'i kadındı. Etanol konsantrasyonu 50 mg/dL olan vakaların sayısı ise 1.084 (%9,3) olarak bulundu. Sonuç: Etanol pozitifliği en sık 20-34 yaş aralığındaki genç yetişkinlerde gözlendi. Dört yıllık süre boyunca, ≤19, 35-50 ve >50 yaş gruplarında etanol pozitifliği oranlarında istikrarlı bir düşüş görüldü.
- Open Access
- 26 March 2025
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (1) , 45-49
Adolesan ve Erişkinlerde Yasadışı Madde Analiz Sonuçlarının Değerlendirilmesi
Amaç: Bu çalışmada, yasadışı madde analiz sonuçlarının yaşa ve cinsiyete göre değerlendirilmesi amaçlandı. Materyal ve metod: Bu retrospektif çalışma kapsamında, Ocak-Haziran 2023 tarihleri arasında AMATEM la-boratuvarında çalışılan yasadışı madde (sentetik kannabinoid-3, kokain, opiat, benzodiazepin, kannabinoid, amfetamin, ekstazi ve eroin) analiz sonuçları hastane bilgi sisteminden elde edildi. Daha sonra madde kullanım dağılımı yaşa [Adolesan (12-17 yaş) ve erişkin (≥18 yaş)] ve cinsiyete göre belirlendi. Bulgular: Toplam 9471 idrar örneği, farklı yaş gruplarına (adolesan yaş grubu: 254, erişkin yaş grubu: 9217) ve cinsiyete (kadın: 346, erkek: 9125) göre yasadışı madde analizi sonuçları açısından incelendi. 9471 idrar örne-ğinin 3724'ünde (%39.3) madde pozitifliği vardı. Adolesanlarda en yüksek madde pozitifliği oranlarının sıra-sıyla amfetamin (%16.1), kannabinoid (%4.7) ve benzodiyazepin (%1.6) olduğu saptandı. Erişkinlerde en yük-sek madde pozitifliği oranları sırasıyla amfetamin (%29.6), kannabinoid (%12.8) ve opiat (%9.7) olarak bu-lundu. Amfetamin, kanabinoid ve opiat pozitiflik oranları erişkinlerde adolesanlara göre anlamlı derecede yük-sekti (tümü için p<0.001). Erkeklerde ve kadınlarda en yüksek görülen madde pozitifliği oranları sırasıyla am-fetamin (%29.8 ve %14.7), kanabinoid (%13 ve %3.8) ve opiat (%9.7 ve %3.5) olarak saptandı. Amfetamin, kannabinoid ve opiat pozitiflik oranlarının kadınlara kıyasla erkeklerde anlamlı derecede daha yüksek olduğu saptandı (tümü için p<0.001). Çoklu madde kullanımında en sık amfetamin–kannabinoid, ikinci sıklıkta ise am-fetamin–opiat ikilisinin olduğu görüldü. Sonuç: Her iki yaş grubu ve cinsiyette en yüksek pozitiflik oranı amfetaminde, ikinci sırada ise kannabinoid maddesinde tespit edildi. Çalışmamızın, yaşa ve cinsiyete göre madde kullanım sıklığı ve profili hakkında bilgi sağlaması nedeniyle madde kullanımına karşı etkili önleyici stratejilerin geliştirilmesinde yararlı olacağını dü-şünmekteyiz.
- 26 March 2025
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 22 (1) , 45-49
Open AccessAdolesan ve Erişkinlerde Yasadışı Madde Analiz Sonuçlarının Değerlendirilmesi
Amaç: Bu çalışmada, yasadışı madde analiz sonuçlarının yaşa ve cinsiyete göre değerlendirilmesi amaçlandı. Materyal ve metod: Bu retrospektif çalışma kapsamında, Ocak-Haziran 2023 tarihleri arasında AMATEM la-boratuvarında çalışılan yasadışı madde (sentetik kannabinoid-3, kokain, opiat, benzodiazepin, kannabinoid, amfetamin, ekstazi ve eroin) analiz sonuçları hastane bilgi sisteminden elde edildi. Daha sonra madde kullanım dağılımı yaşa [Adolesan (12-17 yaş) ve erişkin (≥18 yaş)] ve cinsiyete göre belirlendi. Bulgular: Toplam 9471 idrar örneği, farklı yaş gruplarına (adolesan yaş grubu: 254, erişkin yaş grubu: 9217) ve cinsiyete (kadın: 346, erkek: 9125) göre yasadışı madde analizi sonuçları açısından incelendi. 9471 idrar örne-ğinin 3724'ünde (%39.3) madde pozitifliği vardı. Adolesanlarda en yüksek madde pozitifliği oranlarının sıra-sıyla amfetamin (%16.1), kannabinoid (%4.7) ve benzodiyazepin (%1.6) olduğu saptandı. Erişkinlerde en yük-sek madde pozitifliği oranları sırasıyla amfetamin (%29.6), kannabinoid (%12.8) ve opiat (%9.7) olarak bu-lundu. Amfetamin, kanabinoid ve opiat pozitiflik oranları erişkinlerde adolesanlara göre anlamlı derecede yük-sekti (tümü için p<0.001). Erkeklerde ve kadınlarda en yüksek görülen madde pozitifliği oranları sırasıyla am-fetamin (%29.8 ve %14.7), kanabinoid (%13 ve %3.8) ve opiat (%9.7 ve %3.5) olarak saptandı. Amfetamin, kannabinoid ve opiat pozitiflik oranlarının kadınlara kıyasla erkeklerde anlamlı derecede daha yüksek olduğu saptandı (tümü için p<0.001). Çoklu madde kullanımında en sık amfetamin–kannabinoid, ikinci sıklıkta ise am-fetamin–opiat ikilisinin olduğu görüldü. Sonuç: Her iki yaş grubu ve cinsiyette en yüksek pozitiflik oranı amfetaminde, ikinci sırada ise kannabinoid maddesinde tespit edildi. Çalışmamızın, yaşa ve cinsiyete göre madde kullanım sıklığı ve profili hakkında bilgi sağlaması nedeniyle madde kullanımına karşı etkili önleyici stratejilerin geliştirilmesinde yararlı olacağını dü-şünmekteyiz.
- 30 August 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Yasadışı ve Kötüye Kullanılan Madde Analizinde İdrar Bütünlük Testlerinin İncelenmesi
Amaç: Yasadışı ve kötüye kullanılan madde analizi öncesi yapılan idrar bütünlük testlerinin değerlendirilmesi ve kısıtlılıklarının ortaya konulması amaçlanmıştır. Gereç ve Yöntem: Bu retrospektif çalışmada, 1 Ocak 2023 ile 15 Haziran 2023 tarihleri arasında Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesine bağlı AMATEM laboratuvarında 5495 kişiye ait 8858 idrar numunesinde çalışılan madde analizi (amfetamin, ekstazi, benzodiazepin, esrar, kokain, opiat, eroin ve sentetik kanabinoid-3) ve idrar bütünlük testlerinin (kreatinin, dansite, pH ve nitrit) sonuçları incelendi. Bulgular: İdrar kreatinin değeri 4.52-20 mg/dL arasında olan 116 dilüsyonlu idrar numunesinin 40'ında (%34.5) madde pozitifliği saptandı. İdrar kreatinin değeri 200-400 mg/dL arasında ve 400 mg/dL üzerinde olan numune sayısı sırasıyla 2915 ve 141 idi ve bunların madde pozitifliği oranı ise sırasıyla %46.1 ve %59.6 idi. İdrar dansitesi 1.001-1.003 arasında olan 32 idrar örneği saptanmış olup, bunların 7'sinde (%21.9) madde pozitifliği bulundu. İdrar dansitesi 1.035 üzerinde olan 345 idrar örneğinin 223'ünde (%64.6) madde pozitifliği tespit edildi. Sonuç: Bu sonuçlar, dilüe idrar örneklerinde pozitif madde analizi sonuçları görülebileceğinden, idrar örneklerinin dilüe olsa bile çalışılması gerektiğini göstermiştir. Ayrıca bulgularımız, ulusal kılavuzumuzda yapısı değiştirilmiş idrar örnekleri için tanımlanan kreatinin ve dansite kriterlerinin yeniden değerlendirilmesi gerektiğini desteklemektedir.
- 30 August 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
Yasadışı ve Kötüye Kullanılan Madde Analizinde İdrar Bütünlük Testlerinin İncelenmesi
Amaç: Yasadışı ve kötüye kullanılan madde analizi öncesi yapılan idrar bütünlük testlerinin değerlendirilmesi ve kısıtlılıklarının ortaya konulması amaçlanmıştır. Gereç ve Yöntem: Bu retrospektif çalışmada, 1 Ocak 2023 ile 15 Haziran 2023 tarihleri arasında Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesine bağlı AMATEM laboratuvarında 5495 kişiye ait 8858 idrar numunesinde çalışılan madde analizi (amfetamin, ekstazi, benzodiazepin, esrar, kokain, opiat, eroin ve sentetik kanabinoid-3) ve idrar bütünlük testlerinin (kreatinin, dansite, pH ve nitrit) sonuçları incelendi. Bulgular: İdrar kreatinin değeri 4.52-20 mg/dL arasında olan 116 dilüsyonlu idrar numunesinin 40'ında (%34.5) madde pozitifliği saptandı. İdrar kreatinin değeri 200-400 mg/dL arasında ve 400 mg/dL üzerinde olan numune sayısı sırasıyla 2915 ve 141 idi ve bunların madde pozitifliği oranı ise sırasıyla %46.1 ve %59.6 idi. İdrar dansitesi 1.001-1.003 arasında olan 32 idrar örneği saptanmış olup, bunların 7'sinde (%21.9) madde pozitifliği bulundu. İdrar dansitesi 1.035 üzerinde olan 345 idrar örneğinin 223'ünde (%64.6) madde pozitifliği tespit edildi. Sonuç: Bu sonuçlar, dilüe idrar örneklerinde pozitif madde analizi sonuçları görülebileceğinden, idrar örneklerinin dilüe olsa bile çalışılması gerektiğini göstermiştir. Ayrıca bulgularımız, ulusal kılavuzumuzda yapısı değiştirilmiş idrar örnekleri için tanımlanan kreatinin ve dansite kriterlerinin yeniden değerlendirilmesi gerektiğini desteklemektedir.
- Open Access
- 27 April 2023
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 20 (1) , 19-24
Evaluation of Comorbidities, Laboratory Findings and Clinical Outcomes in Elderly Patients with COVID-19
Background: In this study, we aimed to analyze the underlying diseases, laboratory findings and clinical outcomes of elderly patients infected with COVID-19. We also investigated the value of laboratory parameters in the estimation of critical cases and mortality in elderly patients. Materials and Methods: The study included 314 elderly patients aged 60 years and older who were diagnosed with COVID-19.The patients were divided into two groups according to age, as young old patients (60-74 years) and old old patients (≥75 years). Participants' age, gender, underlying diseases, laboratory findings, disease severity and survival data were obtained from hospital records. Results: The most common comorbidities in elderly patients were hypertension (57.6%), diabetes mellitus (33.8%) and cardiovascular disease (28%). Old old patients had higher rates of critical type (63.4% vs 30.8%, P<0.001) and death (41.9% vs 21.3%, P<0.001) compared to young old patients. The leukocyte count, neutrophil count, urea, creatinine, C-reactive protein (CRP), procalcitonin, ferritin, troponin T, creatine kinase-MB, prothrombin time and D-dimer values were higher in the old old group compared to the young old group. In contrast, hemoglobin and albumin values were lower in the old old group. The areas under the curve (AUC) of albumin, CRP, procalcitonin, ferritin, troponin T and prothrombin time were greater than 0.80 to predict critically elderly COVID-19 patients. Ferritin had the highest AUC for predicting death (AUC: 0.819) followed by CRP (AUC: 0.805) and procalcitonin (AUC: 0.796). Conclusions: We found higher rates of critical type and death in old old patients compared to young old patients. In addition, ferritin, CRP, and procalcitonin were strong predictors of both disease severity and mortality in COVID-19-infected elderly subjects.
- 27 April 2023
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 20 (1) , 19-24
Open AccessEvaluation of Comorbidities, Laboratory Findings and Clinical Outcomes in Elderly Patients with COVID-19
Background: In this study, we aimed to analyze the underlying diseases, laboratory findings and clinical outcomes of elderly patients infected with COVID-19. We also investigated the value of laboratory parameters in the estimation of critical cases and mortality in elderly patients. Materials and Methods: The study included 314 elderly patients aged 60 years and older who were diagnosed with COVID-19.The patients were divided into two groups according to age, as young old patients (60-74 years) and old old patients (≥75 years). Participants' age, gender, underlying diseases, laboratory findings, disease severity and survival data were obtained from hospital records. Results: The most common comorbidities in elderly patients were hypertension (57.6%), diabetes mellitus (33.8%) and cardiovascular disease (28%). Old old patients had higher rates of critical type (63.4% vs 30.8%, P<0.001) and death (41.9% vs 21.3%, P<0.001) compared to young old patients. The leukocyte count, neutrophil count, urea, creatinine, C-reactive protein (CRP), procalcitonin, ferritin, troponin T, creatine kinase-MB, prothrombin time and D-dimer values were higher in the old old group compared to the young old group. In contrast, hemoglobin and albumin values were lower in the old old group. The areas under the curve (AUC) of albumin, CRP, procalcitonin, ferritin, troponin T and prothrombin time were greater than 0.80 to predict critically elderly COVID-19 patients. Ferritin had the highest AUC for predicting death (AUC: 0.819) followed by CRP (AUC: 0.805) and procalcitonin (AUC: 0.796). Conclusions: We found higher rates of critical type and death in old old patients compared to young old patients. In addition, ferritin, CRP, and procalcitonin were strong predictors of both disease severity and mortality in COVID-19-infected elderly subjects.
- Open Access
- 24 January 2023
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 39 (2) , 450-455
Comparing the predictive values of procalcitonin/albumin ratio and other inflammatory markers in determining COVID-19 severity
Objective: To examine the relationship between COVID-19 severity and procalcitonin/albumin ratio (PAR) and compare the PAR with oft-reported inflammatory markers, including procalcitonin, white blood cell (WBC), neutrophil/lymphocyte ratio (NLR) and C-reactive protein (CRP). Methods: In this retrospective research study conducted at Sanliurfa Training and Research Hospital during May to September 2020; total, 577 adult subjects diagnosed with COVID-19 were included and categorized into two groups based on place of hospitalization: the intensive care unit (ICU) group (n=151) and the general ward (GW) group (n=426). Laboratory test results and demographic characteristics of the subjects were recorded. Results: PAR, NLR, CRP, WBC, neutrophil and procalcitonin values were markedly higher in the ICU group than in the GW group. On the contrary, lymphocyte count and albumin level were markedly lower. PAR showed positive correlations with WBC, NLR, and CRP. Multivariate analysis showed that advanced age, presence of hypertension, elevated PAR, WBC, NLR, urea and lactate dehydrogenase levels were independent risk factors associated with the need for intensive care in COVID-19 subjects. Among them, the PAR showed the highest odds ratio (5.564) for ICU admission. Additionally, the area under the ROC curve of the PAR (0.888) was markedly greater than that of WBC (0.777), NLR (0.822), CRP (0.842) and procalcitonin (0.870). Conclusions: This study revealed that PAR was superior to procalcitonin, WBC, NLR and CRP in determining COVID-19 severity. PAR was an important predictor of ICU requirement in COVID-19 cases. doi: https://doi.org/10.12669/pjms.39.2.6856 How to cite this: Damar Çakırca T, Çakırca G, Torun A, Bindal A, Üstünel M, Kaya A. Comparing the predictive values of procalcitonin/albumin ratio and other inflammatory markers in determining COVID-19 severity. Pak J Med Sci. 2023;39(2):450-455. doi: https://doi.org/10.12669/pjms.39.2.6856 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- 24 January 2023
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 39 (2) , 450-455
Open AccessComparing the predictive values of procalcitonin/albumin ratio and other inflammatory markers in determining COVID-19 severity
Objective: To examine the relationship between COVID-19 severity and procalcitonin/albumin ratio (PAR) and compare the PAR with oft-reported inflammatory markers, including procalcitonin, white blood cell (WBC), neutrophil/lymphocyte ratio (NLR) and C-reactive protein (CRP). Methods: In this retrospective research study conducted at Sanliurfa Training and Research Hospital during May to September 2020; total, 577 adult subjects diagnosed with COVID-19 were included and categorized into two groups based on place of hospitalization: the intensive care unit (ICU) group (n=151) and the general ward (GW) group (n=426). Laboratory test results and demographic characteristics of the subjects were recorded. Results: PAR, NLR, CRP, WBC, neutrophil and procalcitonin values were markedly higher in the ICU group than in the GW group. On the contrary, lymphocyte count and albumin level were markedly lower. PAR showed positive correlations with WBC, NLR, and CRP. Multivariate analysis showed that advanced age, presence of hypertension, elevated PAR, WBC, NLR, urea and lactate dehydrogenase levels were independent risk factors associated with the need for intensive care in COVID-19 subjects. Among them, the PAR showed the highest odds ratio (5.564) for ICU admission. Additionally, the area under the ROC curve of the PAR (0.888) was markedly greater than that of WBC (0.777), NLR (0.822), CRP (0.842) and procalcitonin (0.870). Conclusions: This study revealed that PAR was superior to procalcitonin, WBC, NLR and CRP in determining COVID-19 severity. PAR was an important predictor of ICU requirement in COVID-19 cases. doi: https://doi.org/10.12669/pjms.39.2.6856 How to cite this: Damar Çakırca T, Çakırca G, Torun A, Bindal A, Üstünel M, Kaya A. Comparing the predictive values of procalcitonin/albumin ratio and other inflammatory markers in determining COVID-19 severity. Pak J Med Sci. 2023;39(2):450-455. doi: https://doi.org/10.12669/pjms.39.2.6856 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Open Access
- 12 September 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (11) , e14781
Role of NLR, PLR, ELR and CLR in differentiating COVID‐19 patients with and without pneumonia
Objectives Neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), eosinophil/lymphocyte ratio (ELR), and C-reactive protein (CRP)/lymphocyte ratio (CLR) are well-established inflammatory indices. This study aimed to examine whether NLR, PLR, MLR, ELR and CLR could differentiate coronavirus disease 2019 (COVID-19) patients with pneumonia from those of without. Methods We retrospectively examined the laboratory parameters including CRP, D-dimer, procalcitonin, and complete blood count of 306 COVID-19 patients (pneumonic=152 and non-pneumonic=154). NLR, PLR, MLR, ELR, and CLR values of each patient were calculated. The ability of these indices to distinguish COVID-19 patients with and without pneumonia was determined by receiver operating characteristic (ROC) analysis. Results NLR, PLR and CLR values were higher while ELR value was lower in pneumonic COVID-19 patients compared to patients with non-pneumonic COVID-19 infection. MLR value was similar in the two groups. NLR, PLR and CLR were positively correlated with CRP and procalcitonin. ELR was negatively correlated with CRP. The ROC analysis revealed that the optimal cut-off value of CLR for discriminating COVID-19 patients with pneumonia from those without pneumonia was 1.14 and the area under curve (AUC) for CLR was 0.731 (sensitivity= 81.5 % and specificity= 55.6 %), which was higher than the AUCs of NLR (AUC: 0.622), PLR (AUC: 0.585) and ELR (AUC: 0.613). However, no statistical differences were observed between AUC values of NLR, PLR and ELR (p >0.05). Conclusion Our findings showed that NLR, PLR, ELR and CLR indices can be used in differentiating COVID-19 patients with or without pneumonia. Among them, the CLR index was the best predictor of pneumonia in COVID-19 patients.
- 12 September 2021
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (11) , e14781
Open AccessRole of NLR, PLR, ELR and CLR in differentiating COVID‐19 patients with and without pneumonia
Objectives Neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/lymphocyte ratio (MLR), eosinophil/lymphocyte ratio (ELR), and C-reactive protein (CRP)/lymphocyte ratio (CLR) are well-established inflammatory indices. This study aimed to examine whether NLR, PLR, MLR, ELR and CLR could differentiate coronavirus disease 2019 (COVID-19) patients with pneumonia from those of without. Methods We retrospectively examined the laboratory parameters including CRP, D-dimer, procalcitonin, and complete blood count of 306 COVID-19 patients (pneumonic=152 and non-pneumonic=154). NLR, PLR, MLR, ELR, and CLR values of each patient were calculated. The ability of these indices to distinguish COVID-19 patients with and without pneumonia was determined by receiver operating characteristic (ROC) analysis. Results NLR, PLR and CLR values were higher while ELR value was lower in pneumonic COVID-19 patients compared to patients with non-pneumonic COVID-19 infection. MLR value was similar in the two groups. NLR, PLR and CLR were positively correlated with CRP and procalcitonin. ELR was negatively correlated with CRP. The ROC analysis revealed that the optimal cut-off value of CLR for discriminating COVID-19 patients with pneumonia from those without pneumonia was 1.14 and the area under curve (AUC) for CLR was 0.731 (sensitivity= 81.5 % and specificity= 55.6 %), which was higher than the AUCs of NLR (AUC: 0.622), PLR (AUC: 0.585) and ELR (AUC: 0.613). However, no statistical differences were observed between AUC values of NLR, PLR and ELR (p >0.05). Conclusion Our findings showed that NLR, PLR, ELR and CLR indices can be used in differentiating COVID-19 patients with or without pneumonia. Among them, the CLR index was the best predictor of pneumonia in COVID-19 patients.
- 1 September 2021
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 191 (4) , 1925-1930
Thiol level and total oxidant/antioxidant status in patients with COVID-19 infection
Background Accumulating evidence suggests that oxidative stress is closely related to the pathogenesis and severity of COVID-19 infection. Here, we attempted to compare thiol, total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) levels between COVID-19 patients who need and do not need intensive care unit (ICU) support, and determine whether these markers could be used as predictors of ICU admission. Methods We recruited 86 patients with COVID-19 infection and classified them into two groups according to the level of care: ICU group (n = 40) and non-ICU group (n = 46). Thiol, TAS, TOS, and OSI levels were determined and compared between the two groups. Results The levels of thiol and TAS in serum were markedly lower in ICU patients than in the non-ICU patients. On the contrary, TOS and OSI levels were markedly higher. Inflammatory markers, including white blood cell, neutrophil, C-reactive protein, procalcitonin, and ferritin, were negatively correlated with the thiol and TAS, and positively correlated with the TOS and OSI. We determined that areas under the ROC curve for thiol, TAS, TOS, and OSI were 0.799, 0.778, 0.713, and 0.780, respectively. Conclusions Our results revealed that the increase in oxidative stress and decrease in antioxidant levels in COVID-19-infected patients were associated with worsening of disease. Thiol, TAS, TOS, and OSI parameters can be used to distinguish between ICU patients and those who do not, among which thiol was the best predictor of ICU requirement.
- 1 September 2021
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 191 (4) , 1925-1930
Thiol level and total oxidant/antioxidant status in patients with COVID-19 infection
Background Accumulating evidence suggests that oxidative stress is closely related to the pathogenesis and severity of COVID-19 infection. Here, we attempted to compare thiol, total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) levels between COVID-19 patients who need and do not need intensive care unit (ICU) support, and determine whether these markers could be used as predictors of ICU admission. Methods We recruited 86 patients with COVID-19 infection and classified them into two groups according to the level of care: ICU group (n = 40) and non-ICU group (n = 46). Thiol, TAS, TOS, and OSI levels were determined and compared between the two groups. Results The levels of thiol and TAS in serum were markedly lower in ICU patients than in the non-ICU patients. On the contrary, TOS and OSI levels were markedly higher. Inflammatory markers, including white blood cell, neutrophil, C-reactive protein, procalcitonin, and ferritin, were negatively correlated with the thiol and TAS, and positively correlated with the TOS and OSI. We determined that areas under the ROC curve for thiol, TAS, TOS, and OSI were 0.799, 0.778, 0.713, and 0.780, respectively. Conclusions Our results revealed that the increase in oxidative stress and decrease in antioxidant levels in COVID-19-infected patients were associated with worsening of disease. Thiol, TAS, TOS, and OSI parameters can be used to distinguish between ICU patients and those who do not, among which thiol was the best predictor of ICU requirement.